B-type natriuretic peptide to predict ductus intervention in infants <28 weeks

Pediatric Research

Volumn 64, Issue 3, 2008, Pages 286-290

  Czernik, Christoph ^a   Lemmer, Julia ^b   Metze, Boris ^a   Koehne, Petra S ^a   Mueller, Christian ^a   Obladen, Michael ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INDOMETACIN; BIOLOGICAL MARKER;

AORTA ROOT; AREA UNDER THE CURVE; ARTERY LIGATION; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCREENING; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; TREATMENT INDICATION; AORTA; BLOOD; CASE CONTROL STUDY; ECHOGRAPHY; HEART ATRIUM; PREDICTION AND FORECASTING; PROGNOSIS;

AORTA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DUCTUS ARTERIOSUS, PATENT; HEART ATRIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 55749089393     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181799594     Document Type: Article

References (30)

1. Wyllie J 2003 Treatment of patent ductus arteriosus. Semin Neonatol 8:425-432
2. Evans N 1993 Diagnosis of patent ductus arteriosus in the preterm newborn. Arch Dis Child 68:58-61
3. Shimada S, Kasai T, Hoshi A, Murata A, Chida S 2003 Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int 45:255-262
4. Meyers RL, Alpan G, Lin E, Clyman RI 1991 Patent ductus arteriosus, indometh-acin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 29:569-574
5. Bassan H, Feldman H, Limperopoulos C, Benson C, Ringer S, Veracruz E, Soul J, Volpe J, Plessis A 2006 Periventricular hemorrhagic infarction: risk factors and neonatal outcome. Pediatr Neurol 35:85-92
6. Redline RW, Wilson-Costello D, Hack M 2002 Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 52:713-719
7. Evans N, Kluckow M 1996 Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 75:F183-F186
8. Dollberg S, Lusky A, Reichman B 2005 Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 40:184-188
9. Rojas MA, Gonzalez A, Bancalari E, Claure N, Silva-Neto G 1995 Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126:605-610
10. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH 1994 Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93:543-550
11. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL 2001 Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344:1966-1972
12. Marshall DD, Kotelchuk M, Young TE, Bose CL, Kruyer L, O'Shea TM 1999 Risk factors for chronic lung disease in the surfactant era: a North Carolina populationbased study of very low birth weight infants. Pediatrics 104:1345-1350
13. Vanderheyden M, Bartunek J, Goethals M 2004 Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 6:261-268
14. Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G 2003 Biological variation for N-terminal Pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628-631
15. Puddy VF, Amirmansour C, Williams AF, Singer DR 2002 Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 103:75-77
16. Holmstrom H, Omland T 2002 Natriuretic peptides as markers of patent ductus arteriosus in preterm infants. Clin Sci 103:79-80
17. Holmstrom H, Hall C, Thaulow E 2001 Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184-191
18. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T 2005 Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25:709-713
19. Flynn PA, da Garca RL, Auld PA, Nesin M, Kleinman CS 2005 The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147:38-42
20. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, Lee JW 2005 Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115:e255-e261
21. Fleiss JL 1981 Statistical Methods for Rates and Proportions, 2nd Ed. Wiley & Sons, New York, pp 38-45
22. Papile LA, Burstein J, Burstein R, Koffler H 1978 Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92:529-534
23. Evans N, Iyer P 1994 Assessment of ductus arteriosus shunt in preterm infants supported by mechanical ventilation: effect of inter-atrial shunting. J Pediatr 125:778-785
24. Evans N, Iyer P 1995 Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 72:F156-F161
25. Kluckow M, Evans N 1995 Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774-779
26. Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M 2006 Comparable increase of B-type natriuretic peptide and amino-terminal pro-Btype natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34:2140-2144
27. Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J 2002 Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110:e76
28. Bar-Oz B, Lev-Sagie A, Arad I, Salpeter L, Nir A 2005 N-terminal pro-Btype natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem 51:926-927
29. Koch A, Singer H 2003 Normal values of B type natriuretic peptide in infants, children and adolescents. Heart 89:875-878
30. Iyer P, Evans N 1994 Re-evaluation of the left atrial to aortic root ratio as marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70:F112-F117